Drug Type Peptide Conjugate Radionuclide |
Synonyms- |
Target |
Mechanism Tubulin inhibitors, αvβ6 antagonists(Integrin alpha-V/beta-6 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | US | 01 Sep 2011 |